According to the Kaplan–Meier survival curves analysis, COAD patients with higher FDX1 expression showed that overall survival (OS) and disease-specific survival (DSS) were higher than that of the low expression group (P < 0.05, Fig. 2A, B). The gene discussed is FDX1; the disease is colon adenocarcinoma.